T2 Biosystems's current cash is $2.1M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest current cash for TTOO is $2.1M as of September 2024. That compares with $24M in the prior-year period — down 91.4% year over year. Investors often review this figure alongside T2 Biosystems's historical trend and sector peers before judging valuation or financial health.
Over the past year, TTOO's current cash moved from $24M to $2.1M — a 91.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in T2 Biosystems's operating scale or balance-sheet position.
A current cash figure of $2.1M for TTOO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting TTOO's current cash ($2.1M), review year-over-year change from $24M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack T2 Biosystems's current cash against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.